Search
Mirum Pharmaceuticals Inc
MIRMAdd to Watchlist
92.080USD
+0.250+0.27%
Market hours 09/21, 15:09（ET）
5.96BMarket Cap
LossP/E TTM
Mirum Pharmaceuticals Inc (MIRM) Revenue Performance
Updated: Jun 30, 2026By Business
Revenue
Proportion
Annual
Annual
Quarterly
Livmarli
Bile Acid Medicines
License and other revenue
FY2025
FY2024
Livmarli
360.01M(69.06%)
213.29M(63.31%)
Bile Acid Medicines
161.31M(30.94%)
123.11M(36.54%)
License and other revenue
--(--)
479.00K(0.14%)